Safety and feasibility of curved lead simultaneously implanted into pedunculopontine nucleus and subthalamic nucleus

查看全文 作　　者：Wei [1]Wang;Xiaoyong [2]Chen;Deyuan [3]Chen;Yue [2]Chen;Lianghong [2]Yu;Yuanxiang [2]Lin;Dezhi [2]Kang;Xiangrong [4]Chen;Chenyu [2]Ding 机构地区：[1]Department of Neurosurgery,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325000,China;[2]Department of Neurosurgery,Neurosurgical Research Institute,The First Affiliated Hospital,Fujian Medical University,Fuzhou,Fujian 350005,China;[3]Department of Pathology,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325000,China;[4]Department of Neurosurgery,The Second Affiliated Hospital of Fujian Medical University,Quanzhou,Fujian 362000,China 出　　处：《Chinese Medical Journal》索引2022年第135卷第20期,共3页 基　　金：National Natural Science Foundation of China(No. 81901395) 摘　　要：To the Editor:Combined nuclei stimulation may have a synergistic effect on controlling the symptoms of nervous system diseases and improving quality of life.[1]However,increasing of leads may increase costs and complications.[2]Therefore,our study aims to investigate the safety and feasibility of the single curved lead,which can simultaneously reach both subthalamic nucleus(STN)and pedunculopontine nucleus(PPN). 关 键 词：curved SIMULTANEOUS SYNERGISTIC